Skip to main content
Tenders

Insulin pumps, continuous glucose monitoring products contributing to the delivery of hybrid closed loop pathways and associated products

Open
Deadline
87 days left
June 22, 2026
Contract Details
Category
Other
Reference
010763-2026
Value
£3,600,000,000
Location
United Kingdom
Published
March 19, 2026
CPV Code
Project Timeline

Tender Published

February 06, 2026

Deadline for Questions

June 15, 2026

Submission Deadline

June 22, 2026

Contract Start Date

May 31, 2027

Buyer IntelligencePRO
🔒
Unlock Buyer Intelligence
See spending patterns, preferred procedures, and more.
Upgrade to Professional →
Budget
£3,600,000,000
Duration
96 months
Location
United Kingdom
Type
Other
78
Quality Score/100
Good

Original Tender Description

NHS Supply Chain supports national diabetes services by enabling equitable access to advanced diabetes technologies, encouraging openness to innovation, and ensuring an appropriate balance between clinical outcomes, cybersecurity, interoperability, and value for money. This notice is published to inform the market and to invite suppliers to participate in preliminary market engagement in accordance with the Procurement Act 2023. NHS Supply Chain is exploring the potential establishment of an open framework agreement with a proposed duration of up to eight (8) years for the supply of insulin pumps, continuous glucose monitoring (CGM) devices, hybrid closed loop system components, and associated products and services. The proposed scope may include, but is not limited to, tethered insulin pumps, patch insulin pumps, continuous glucose monitoring devices, products contributing to the functionality of hybrid closed loop insulin delivery systems, consumables, and smart insulin pens. Precise quantities are unknown. It is anticipated that indicative expenditure in the first year may be in the region of £240,000,000 to £250,000,000 GBP (excluding VAT). This estimate is indicative only and may vary depending on the requirements of contracting authorities accessing the framework. The estimated total value over the potential eight year duration is approximately £3,000,000,000 GBP (excluding VAT). Any future framework agreement would support delivery of the NHS England Implementation Plan following the National Institute for Health and Care Excellence (NICE) Technology Appraisal TA943 – Hybrid closed loop systems for managing blood glucose levels in type 1 diabetes, published on 19 December 2023. Participation in this preliminary market engagement is voluntary and does not constitute a commitment by NHS Supply Chain to commence a procurement, to award a contract, or to include any participant in any future procurement process. Any future procurement will be conducted in accordance with the Procurement Act 2023 and published via the Find a Tender Service as appropriate. Any resulting framework agreement would be entered into between NHS Supply Chain and the appointed supplier(s)

Risk Analysis

Please log in to use risk analysis.

Login

Win Strategy

Please log in to access winning strategy recommendations.

Login

Competitors

Upgrade to see which companies are likely to bid on this tender, based on historical procurement data.

Login

Requirements & Qualifications

9 requirements across 5 categories

Submission (3)
Mandatory (1)
Compliance (2)
Technical (2)
Financial (1)
SUBMISSION REQUIREMENTS3
--Participate in the preliminary market engagement process as invited by NHS Supply Chain.
--Respond to the invitation for preliminary market engagement by the deadline of 2026-06-22T00:00:00.
--Engage with NHS Supply Chain to discuss the potential establishment of an open framework agreement for diabetes technologies.
MANDATORY EXCLUSION GROUNDS1
--No specific mandatory exclusion grounds are stated for this preliminary market engagement. These will apply to any future formal procurement in accordance with the Procurement Act 2023.
ELIGIBILITY REQUIREMENTS2
--Be a supplier of advanced diabetes technologies, including insulin pumps, continuous glucose monitoring (CGM) devices, hybrid closed loop system components, and associated products and services.
--Be a supplier interested in participating in preliminary market engagement for a potential eight-year framework agreement with NHS Supply Chain.
TECHNICAL CAPABILITY REQUIREMENTS2
--Possess the capability to supply a range of diabetes technologies, including tethered insulin pumps, patch insulin pumps, continuous glucose monitoring devices, products contributing to hybrid closed loop insulin delivery systems, consumables, and smart insulin pens.
--Demonstrate an understanding of and ability to contribute to requirements related to clinical outcomes, cybersecurity, interoperability, and value for money in advanced diabetes technologies.
FINANCIAL REQUIREMENTS1
--No specific financial requirements are stated for this preliminary market engagement. Financial assessments will likely be part of any future formal procurement.

Requirements Preview

Sign up to view complete requirements and analysis

Documents

4 documents available with AI summaries

Planning NoticeHTM
010763-2026.html

This notice invites suppliers to participate in voluntary preliminary market engagement for a potential £3 billion, 8-year framework agreement for insulin pumps, continuous glucose monitoring devices, and associated diabetes technologies for NHS Supply Chain.

OCDS RecordDOC
010763-2026_ocds_record.json

Download failed - no summary available

OCDS Release PackageDOC
010763-2026_ocds_release.json

This document is an OCDS release package detailing a preliminary market engagement by NHS Supply Chain for a potential £3 billion framework agreement over eight years for insulin pumps, continuous glucose monitoring devices, and related diabetes technologies.

Official PDF VersionPDF
010763-2026_official.pdf

This notice invites suppliers to participate in preliminary market engagement for a potential £3 billion, eight-year framework agreement for insulin pumps, continuous glucose monitoring devices, and associated diabetes technologies for NHS Supply Chain.

Documents Preview

Sign up to view document summaries and analysis

78
Good

Tender Quality Score

This is a well-structured preliminary market engagement notice for a significant framework agreement. While it lacks formal tender elements like evaluation criteria and e-submission, this is appropriate for its 'planning' status and PME nature.

Score Breakdown

Legal Compliance90/100

The notice clearly defines itself as a preliminary market engagement (PME) and references the UK Procurement Act 2023, indicating compliance with national regulations for this stage. The CPV code is appropriate, and there are no disputes or suspensions.

Clarity85/100

The description is very clear and unambiguous, explaining the purpose, scope, and potential duration/value of the future framework agreement. The requirements, as extracted, are clear within the context of a PME.

Completeness70/100

Basic information (title, reference, organization, value, duration) is present. Requirements for PME participation are defined. However, one document failed to download, which is a minor completeness issue.

One document failed to download
Fairness85/100

The PME is explicitly open and voluntary, indicating a fair approach to market engagement. Requirements are generic and not tailored. The absence of e-submission is a minor drawback for equal access.

Absence of e-submission functionality
Practicality65/100

The lack of e-submission functionality is a significant practical drawback for participation. Other practical details like contract start date and duration are clearly specified.

Absence of e-submission functionality
Data Consistency90/100

Data is largely consistent and logical, with dates aligning appropriately. The estimated values in GBP and EUR are roughly consistent. The 'Liable Person' field is empty, which is a minor inconsistency.

Liable Person field is empty
Sustainability50/100

The notice explicitly mentions 'encouraging openness to innovation' and 'advanced diabetes technologies,' which is a positive. However, there are no explicit green procurement or social criteria mentioned.

No explicit green procurement criteria
No explicit social criteria

Strengths

Clear identification as a Preliminary Market Engagement (PME)
Comprehensive description of the potential framework's scope and objectives
High estimated value and long duration clearly specified
Explicit mention of encouraging innovation and balancing clinical outcomes, cybersecurity, interoperability, and value for money
Reasonable timeline for market engagement participation

Concerns

Absence of e-submission functionality for participation
Lack of explicit green procurement or social responsibility criteria
One document failed to download, indicating a minor technical issue
"Liable Person" field is empty
No formal evaluation criteria or performance conditions (though expected for a PME)

Recommendations

1. Implement electronic submission capabilities for future formal procurements to enhance accessibility and efficiency.
2. Integrate explicit sustainability (green and social) criteria into the future framework agreement.
3. Ensure all tender documents are fully accessible and downloadable.

AI Scoring Preview

Sign up to view complete requirements and analysis

Complete quality score analysis
Detailed sub-score breakdown
Strengths & concerns insights
Strategic recommendations

No credit card required • Setup in 2 minutes

New Service

Want us to handle this tender?

Our procurement experts prepare everything. Proven to work — you review, approve, and submit.

~1hYour time only
80%+80%+
$0Upfront
See full comparison
Without TaaSWith TaaS
40-80 hrs
Preparation time
~1 hr
Your time only
15-25%
Average win rate
80%+
Win rate
Risk of errors
Manual review
Expert QA
Compliance check
You do all
Handle everything
We do all
End-to-end service
Let's Win This Tender
Pay only when you win · 400+ companies trust us
Or do it yourself

Add to Pipeline